coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Care Collaborative (redhill) PCN, Reigate and Banstead · Health Inequalities Profile

    PCN U57300 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    61,014

    Registered population

    61.4% aged 18–64

    15.8%

    Aged 65+

    ICB 18.8% · England 17.9%

    16.9%

    Ethnic minority (non-White)

    8.2% Asian · England 9.6%

    2.8%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    ~1,631

    Core20 residents (est.)

    Resident basis; registered basis ~1,695 · see page 3

    6,222

    Hypertension register

    +6.32% in 3 yrs · England +5.60%

    470

    SMI register

    40.8% of Reigate and Banstead's

    637

    COPD register

    Reviews -20.12% in 3 yrs

    Forecast to 2030

    7,477

    Hypertension patients, 2030

    +1,255 on today

    62.6%

    QRISK ≥20% on statins, 2030

    +1.37pp over 3 yrs

    4.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -20.1%
    COPD annual review completion fell over 2023–2025.

    COPD annual reviews fell 20.1% over 2023 to 2025 to 68.6% (England +2.8%, 76.4%) while register prevalence grew +8.3%, which may reflect recall pressure.

    56.8 pp
    Vaccination and Core20 gaps sit in one practice.

    QOF vaccination achievement spans 56.8 pp from 27.2% at The House Partnership (Core20 4.4%) to 84.0% at The Wall House Surgery (Core20 0.0%).

    73.7%
    Hypertension blood pressure control exceeds comparator benchmarks.

    Blood pressure control reaches 73.7% (England 70.3%), though recorded prevalence is 12.1% (England 15.2%), which may reflect a younger list (15.8% aged 65+).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger list with 22.8% aged 0-17 contrasts with 1,329 catchment care beds

    The PCN registers 61,014 patients across The House Partnership (38,701) and The Wall House Surgery (22,313). Those aged 0-17 comprise 22.8%, above Reigate and Banstead (21.0%), the ICB (20.4%) and England (19.6%), while 15.8% are aged 65+ (borough 19.4%, ICB 18.8%, England 17.9%). Area Census residents are 83.1% White (borough 84.4%, ICB 85.3%, England 81.1%) and 8.2% Asian (borough 7.5%, ICB 7.7%, England 9.6%), describing local residents rather than registered patients. Projected list growth to 2030 is +4.8% (borough +3.2%, ICB +4.9%, England +2.3%), based on an unverified methodology.

    Age profile

    0–1722.8%
    18–6461.4%
    65+15.8%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White83.1%
    Asian8.2%
    Mixed3.9%
    Black3.3%
    Other1.5%

    Older people · falls rows are Reigate and Banstead local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Reigate and Banstead LA)2,1542,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.7%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.9%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Reigate and Banstead LA)9919819552024/25
    Falls deaths, all ages, per 100,000 (Reigate and Banstead LA)8.914.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 2.8% PCN-wide and concentrated entirely at The House Partnership

    The PCN records an average IMD decile of 7.6 (Reigate and Banstead 8.0, ICB 7.9, England 5.5). Its Core20 share of 2.8% is below England (21.0%) but above Reigate and Banstead (1.1%) and the ICB (0.8%). Deprivation sits entirely at The House Partnership (4.4% Core20 share, an estimated 1,695 patients), whereas The Wall House Surgery has 0.0%. Resident estimates show 1,631 people in one decile-2 LSOA, though practice and resident counts use different bases. Core20 outreach is therefore best directed to The House Partnership.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    House Partnership4.4% · 1,695 patients
    Wall House0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    470

    SMI register

    0.92% recorded prevalence

    298

    Learning disability register

    0.58% recorded prevalence

    48

    Care homes, 1,329 beds

    In the PCN catchment

    7.9%

    Provide unpaid care

    Reigate and Banstead, Census 2021

    Recorded prevalence is 0.9% for severe mental illness (470 patients) and 0.6% for learning disability (298 patients), representing 40.8% and 36.8% of borough registers. Catchment areas include 48 care homes (1,329 beds). Borough rough sleeping (6 in 2025) does not describe registered lists.

    Severe mental illness: physical health checks

    Over three years, SMI physical checks fell: BMI recording dropped 8.2 pp to 79.6% (England +5.1 pp) and blood pressure checks fell 3.7 pp to 82.0% (England +4.4 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,222

    Hypertension register

    +6.32%

    Register growth, 3 yrs

    Reigate and Banstead +4.55% · England +5.60%

    +2.87pp

    BP control, under 80

    ≤140/90 · +2.45pp aged 80+

    +1,255

    More patients by 2030

    Forecast 7,477 (13.70%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 12.1% (6,222 patients), below Reigate and Banstead (14.0%), NHS Surrey Heartlands ICB (14.3%) and England (15.2%), consistent with a younger list (15.8% aged 65+ vs England 17.9%). Blood pressure control is strong overall: 73.7% are treated to target (England 70.3%), and under-80 control is 70.9% (England 67.8%). However, achievement is uneven: at The House Partnership, 66.7% are treated to target and 63.8% of under-80s achieve control, versus 82.5% and 80.4% at The Wall House Surgery. Blood pressure control falls below England at The House Partnership, so focused blood pressure review and recall at that practice should be prioritised.

    Lipids and statins

    Among patients with QRISK ≥ 20%, 59.7% receive lipid-lowering therapy (England 63.6%, NHS Surrey Heartlands Integrated Care Board 59.4%). Primary-prevention statin coverage in diabetes fell 3.3% over three years to 69.5% (England 73.2%, +2.1%). Fewer at-risk patients are on lipid-lowering therapy than England, suggesting scope for primary-prevention recall.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202652,579£2.10£2.24£1.86£110,416
    Cardiovascular (all), 202574,106£4.28£4.74£3.33£317,174

    In 2026, the PCN prescribed 52,579 lipid-regulating drug items at £2.10 per item (England £1.86, NHS Surrey Heartlands ICB £2.24), spending £12,619 more than at England's unit cost but £7,361 less than at NHS Surrey Heartlands Integrated Care Board's unit cost. Higher unit costs than England indicate an opportunity to review lipid-regulating formulary choices without restricting indicated treatment.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +1.24%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −4.08%

    Asthma prevalence, PCN 3-yr % change

    The COPD register grew +8.3% over three years to 637 patients (England +2.6%), but annual review completion fell 20.1% to 68.6% (England +2.8%), reaching 60.5% at The House Partnership and 83.8% at The Wall House Surgery. Asthma prevalence fell 4.1% over three years to 6.3% (England +0.5%) across 3,018 patients; a 65.6% review rate leaves an estimated 1,037 patients without an annual review. Prescribing for ages 5-19 is 829 items per 1,000 (England 1,488).

    Cancer register and children's immunisation

    The cancer register records 1,963 patients (3.8%, England 3.8%). In Q1 2025/26 child health, 12-month 6-in-1 coverage is 88.0%, below the 95% target by 7 pp, while 24-month coverage is 96.5%. At age 5, MMR first-dose coverage is 97.3% and second-dose coverage is 93.2%, a 4.1 pp difference between doses in the same cohort.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months88.0%

    England 91.0%

    6-in-1 complete primary course at 24 months96.5%

    England 92.2%

    MMR dose 1 at 24 months91.5%

    England 88.3%

    MMR dose 2 at age 593.2%

    England 82.8%

    4-in-1 pre-school booster at age 591.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    In 2022, NHS Surrey Heartlands ICB diagnosed 61.4% of cancers with a known stage at stage 1 or 2 (England 55.3%), below the 75.0% national ambition by 2028, requiring about 650 extra early-stage cases annually across the ICB. Known-stage completeness was 67.7% (England 67.0%). These ICB figures reflect system context rather than PCN performance. Locally, PCN cervical screening coverage in women aged 25 to 49 is 69.7% after falling 3.3% over 2023 to 2025 (England -1.0%), dropping to 64.0% at The House Partnership, while breast screening reached 70.2% (+10.0% over 2023 to 2024; England +8.4%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Surrey and Sussex Healthcare NHS Trust achieved 77.7% on the 28-day faster diagnosis standard against the 75.0% standard (Croydon Health Services NHS Trust 83.2%, Epsom and St Helier University Hospitals NHS Trust 89.7%, NHS Surrey and Sussex Integrated Care Board 79.3%, England 79.3%). Its 62-day referral to treatment performance was 70.0% against the 85.0% standard (Croydon Health Services NHS Trust 69.9%, Epsom and St Helier University Hospitals NHS Trust 86.8%, NHS Surrey and Sussex Integrated Care Board 71.5%, England 71.2%). Across all diagnostic tests, 28.5% of patients waited 6+ weeks (England calculated: 23.1%).

    Pathways within standard (%)Surrey and Sussex HealthcareEpsom and St HelierCroydon HealthSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)77.7489.7083.2279.2979.32
    31-day treatment (96%)96.2099.1699.0690.4592.50
    62-day referral to treatment (85%)69.9786.8269.8871.5171.16
    Diagnostic waits over 6 weeks (%)Surrey and Sussex HealthcareEpsom and St HelierCroydon HealthEngland
    MRI27.530.310.2621.40
    CT18.491.067.699.92
    Echocardiography43.7825.493.6028.48
    Colonoscopy15.1133.0121.8030.83
    Gastroscopy21.0630.9017.9429.02
    All 15 DM01 tests28.506.833.5123.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In June 2026, Surrey residents recorded 109,530 provisional community care contacts across 33,510 patients, with 69.6% of contacts involving adults aged 65+. Across NHS Surrey and Sussex Integrated Care Board, 85,660 patients had 309,615 contacts and 47,125 patients received 66,930 referrals. These experimental figures reflect broad county and system activity rather than PCN caseloads.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Vaccination achievement spans 56.8 pp between practices, alongside divergent patient satisfaction scores

    Both practices achieved 100.0% in the 2025/26 QOF clinical domain (England 97.1%). Overall achievement reached 91.7% at The House Partnership and 98.2% at The Wall House Surgery. However, vaccination and immunisation achievement diverged by 56.8 pp, from 27.2% at The House Partnership (England 55.2%) to 84.0% at The Wall House Surgery.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Wall House1160.062.0%71.6%83.9%
    House Partnership1074.470.3%62.5%74.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNReigate and BansteadAssetPCNReigate and Banstead
    Care homes (catchment)48 (1,329 beds)n/aSchools (catchment)69n/a
    Children's centres58Places of worship6470
    Libraries56Food banks (VCS)66
    Homelessness support (VCS)12Day centres (VCS)2340
    Children and young people (VCS)78Carers support groups (VCS)66
    Primary schools (LA maintained)1114Primary academies1618

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Targeted Core20 and vaccination outreach

    QOF vaccination achievement spans 56.8 pp (27.2% at The House Partnership vs 84.0% at The Wall House Surgery; England 55.2%), and all 1,695 estimated Core20 patients (4.4%) sit at The House Partnership. For discussion: concentrate proactive immunisation catch-up, call-recall review and flexible clinic slots at The House Partnership. Moderate effort to run.

    Evidence base: the share of patients in the most deprived quintile is the Core20 targeting measure used to weight inequalities funding, outreach and prevention capacity, and the gradient every clinical indicator should be read against.

    Policy anchor: Core20PLUS5 (Core20 = the most deprived 20% by IMD); 10 Year Health Plan, with widening inequalities the equity test of reform.

    Option 2

    Respiratory annual review recall reset

    COPD reviews fell 20.1% over 2023 to 2025 to 68.6% across 637 patients (England 76.4%, +2.8%; The House Partnership 60.5% vs The Wall House Surgery 83.8%), and 65.6% asthma review coverage across 3,018 patients leaves about 1,000 unreviewed. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 3

    SMI physical health check consolidation

    Across 470 SMI patients (0.9%, 40.8% of the borough register), 2023 to 2025 recording fell for BMI (8.2 pp to 79.6%, England +5.1 pp), alcohol (7.1 pp to 79.4%, England +5.4 pp) and BP (3.7 pp to 82.0%, England +4.4 pp). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Paediatric demand capacity planning (p2)Aged 0-17Medium Term Planning Framework 2026 · Neighbourhood health frameworkPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall audit (p4)Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension control recall audit (p5)Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029Practice
    Infant immunisation recall review (p6)6-in-1 coverage at 12 months10YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Appointment booking workflow review (p9)GPPS last request led to a booked appointment10YHP, hospital to communityPractice
    Option 1 · Targeted Core20 and vaccination outreach (p12)Core20 cohort (IMD quintile 1) · QOF vaccination and immunisation-domain achievementCore20PLUS5 · 10YHP equity testPCN & Practice
    Option 2 · Respiratory annual review recall reset (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 respiratoryPCN & Practice
    Option 3 · SMI physical health check consolidation (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15